Skip to main content
Article
SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease
The Lancet Diabetes & Endocrinology (2019)
  • Katherine R Tuttle, University of Washington
Publication Date
June 1, 2019
DOI
10.1016/s2213-8587(19)30116-0
Citation Information
Katherine R Tuttle. "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease" The Lancet Diabetes & Endocrinology Vol. 7 Iss. 6 (2019) p. 414 - 415
Available at: http://works.bepress.com/katherine-tuttle/219/